Laboratory analysis of ranitidine and nizatidine products – Safety update
November 1, 2019 - Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, provided an update regarding the ongoing investigation of the N-Nitrosodimethylamine (NDMA) impurity in prescription and over-the-counter ranitidine products.
Top